Kensey Nash Predicts Orthopedic Growth In 2006 After Orthovita Disappoints

Kensey Nash expects that updating the Vitoss Foam bone-void filler line will revive sluggish sales to biomaterials company Orthovita in 2006

More from Archive

More from Medtech Insight